Verastem (VSTM) Revenue (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.48% |
| Dec 31, 2025 | 55.98% |
| Sep 30, 2025 | 426.06% |
| Mar 31, 2022 | 376.33% |
| Dec 31, 2021 | 27,150.00% |
| Sep 30, 2021 | -99.60% |
| Jun 30, 2021 | -50.30% |
| Mar 31, 2021 | 98.81% |
| Dec 31, 2020 | -99.36% |
| Sep 30, 2020 | 1,726.03% |
| Jun 30, 2020 | -14.81% |
| Mar 31, 2020 | 39.78% |
| Dec 31, 2019 | -59.95% |
| Sep 30, 2019 | 188.01% |
| Jun 30, 2019 | 87.67% |
| Mar 31, 2019 | 38.10% |
| Dec 31, 2018 | -92.20% |
| Sep 30, 2018 | 55.08% |